4//SEC Filing
ALEXION PHARMACEUTICALS INC 4
Accession 0000899866-16-000355
CIK 0000899866operating
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:34 PM ET
Size
6.9 KB
Accession
0000899866-16-000355
Insider Transaction Report
Form 4
Thiel Carsten
SVP, EMEA & Asia Pacific
Transactions
- Sale
Common Stock, par value $.0001 per share
2016-09-12$124.20/sh−225$27,945→ 40,354 total - Sale
Common Stock, par value $.0001 per share
2016-09-13$129.00/sh−3,000$387,000→ 37,354 total
Footnotes (3)
- [F1]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
- [F2]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $124.00 - $124.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $129.00 - $129.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
Documents
Issuer
ALEXION PHARMACEUTICALS INC
CIK 0000899866
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000899866
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:34 PM ET
- Size
- 6.9 KB